drugset / Trial / NCT02562963
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
Phase 1/2
Unknown
120 enrolled
Minghui Zhang
First Hospital of Tsinghua University · collabShanghai Public Health Clinical Center · collab
NaSingle-groupOpen-labelTreatment
Summary
Natural killer T (NKT) cells are a unique subset of lymphocytes that present a mixed T-NK phenotype. Our hypothesis is that Natural killer T cells may decrease the tumor burden and improve overall survival. The purpose of this study is to determine whether Natural killer T (NKT) cells are effective and safe in the treatment of patients with unresectable advanced solid tumor.
Timeline
- Start
- 2015-11
- Primary completion
- 2023-05
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | natural killer T cell | Cell therapy | 4e+09 cells | — |